Ra Capital Management, L.P. Novavax Inc Transaction History

Ra Capital Management, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$36.28 - $75.29 $25.1 Million - $52.2 Million	-692,794 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $98 Million - $201 Million	-1,405,000 Reduced 66.98%	692,794 $51 Million
Q3 2021 Nov 15, 2021	SELL	$177.8 - $270.58 $82.2 Million - $125 Million	-462,124 Reduced 18.05%	2,097,794 $435 Million
Q2 2021 Aug 16, 2021	SELL	$121.0 - $257.67 $53.5 Million - $114 Million	-442,169 Reduced 14.73%	2,559,918 $543 Million
Q1 2021 May 17, 2021	SELL	$112.98 - $319.93 $88.9 Million - $252 Million	-786,477 Reduced 20.76%	3,002,087 $544 Million
Q4 2020 Feb 16, 2021	BUY	$78.74 - $139.5 $204 Million - $361 Million	2,589,962 Added 216.08%	3,788,564 $422 Million
Q3 2020 Nov 16, 2020	SELL	$79.44 - $178.51 $283 Million - $636 Million	-3,560,231 Reduced 74.81%	1,198,602 $130 Million
Q2 2020 Aug 14, 2020	BUY	$13.86 - $83.61 $66 Million - $398 Million	4,758,833 New	4,758,833 $397 Million

290

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $676M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Ra Capital Management, L.P., based on Form 13F filings with the SEC.

Stay updated on Ra Capital Management, L.P. with notifications on news.